Navigation Links
KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
Date:8/28/2007

Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds

in Merck KGaA Pipeline

EMERYVILLE, Calif., Aug. 28 /PRNewswire/ -- KineMed, Inc., a pathway-based drug discovery and development company, announced today that it will collaborate with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to discover new applications for drug candidates. KineMed's proprietary pathway-based drug discovery and development technology identifies compounds that can modulate key metabolic pathways present in both preclinical animal models and in humans. By measuring real-time activity of drugs against these targeted pathways, KineMed's technology reduces development risk by selecting drug candidates with the best potential to demonstrate clinical efficacy and confirm desired drug activity in first-in-man studies.

In the collaboration, KineMed will identify new therapeutic utility in in vivo preclinical models by applying its proprietary translational medicine technologies. Once a disease target is established for a selected drug candidate, KineMed and Merck KGaA will jointly determine the best development and commercialization path for the development candidates being studied.

Under the terms of the agreement, KineMed will receive from Merck an upfront payment, milestones and royalty payments on products advanced with KineMed's technology. Additional terms of the deal were not disclosed.

David Fineman, President and CEO of KineMed, commented, "We are pleased to expand our relationship with Merck KGaA into this broader development collaboration. Our technology uniquely enables our partners to screen development candidates against KineMed's dynamic targets of pathway kinetics. Partnering with KineMed further enables its partners to rapidly demonstrate on-mechanism dose response in first-in-man studies with KineMed's unique translational medicine capabilities."

Mr. Fineman continued, "In this collabo
'/>"/>

SOURCE KineMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GE, St. Jude to collaborate on visualization technology
2. GE Healthcare, MobileAccess to collaborate on hospital wireless
3. GE Healthcare, Harvard medical school to collaborate on nervous system research
4. Madison, Milwaukee med schools to collaborate on tech transfer
5. EraGen collaborates with Emory University on HIV detection system
6. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
7. Silencer Validated siRNAs
8. Using Validated siRNAs in Functional Genomic Assays
9. YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
10. YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
11. Stem cell bank announcement validates quality of Wisconsin research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Ambassador to Speak at Economic C...Canada (Vocus) November 25, 2009 -- Ambassador to ...avid Appia, French Ambassador for International In...ance Agency ,To view a biography of David Appia go...dor Appia is available to meet with press to discu...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/ -... and provider of vaccines, announced today that it...ish Sinovac (Dalian) Vaccine,Technology Co., Ltd. ...roduce,and commercialize human-use vaccines. Sinov... developing and commercializing world-class vaccin...
(Date:11/24/2009)...elease is available in German . , Whether i...ds: RFID tags (Radio Frequency Identification) are.... They make it possible to label objects or goods .... The appropriate scanner can read and process the...affixed to goods under production conditions of up...
(Date:11/24/2009)... The New York investment bank KTA ...EU) has agreed an AU$6.7 mil convertible note priv...The private placement was arranged by KTA Capital ... , New York (PRWEB) Novem...t bank KTA Capital, LLC ("KTA Capital") ...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...et Exchange Agreement, COPENHAGEN, September 13 ...n of an asset exchange agreement with,Medarex, Inc...ceive full,rights to HuMax-Inflam(TM)/MDX-018, whi...hts to multiple disease programs in oncology. Genm...iously held economic interests,in the assets excha...
...2 Schering-Plough,Corporation (NYSE: SGP ) annou...ggregate principal amount of 6.00% Senior Notes du...f 6.55% Senior Notes due 2037 through,an underwrit...pected to,close on Sept. 17, 2007, subject to cust...for the offering is Goldman, Sachs & Co. The,joint...
...2 PPD, Inc. (Nasdaq:,PPDI) today announced Daniel...ficer. He will assume his position on October 1. ... Honeywell,International, a $34 billion diversifie...st recently served as vice president and CFO of fi...s at Honeywell, he was CFO of,the company,s global...
Other Biology Technology:Genmab Announces Asset Exchange Agreement 2Schering-Plough Announces Pricing of Senior Notes Offering 2Schering-Plough Announces Pricing of Senior Notes Offering 3PPD Names Daniel Darazsdi as Chief Financial Officer 2PPD Names Daniel Darazsdi as Chief Financial Officer 3
(Date:11/24/2009)...N ROUGE Antarctica has long held secrets of the e... recently, there has been very little information ...miles of ice for millions of years. Now, a team of... have been funded to the tune of $10 million doll... get to the bottom of things literally. These sci...
(Date:11/23/2009)...gton, D.C. The community-associated strain of the... resistant to most common antibioticsposes a far g...making its way into hospitals, according to a stud...seases . , The new threat is easily picked up i...s and has increased the overall burden of MRSA wit...
(Date:11/23/2009)...gton, CT Current research suggests that a common ... The related report by Nichols et al, "Unique Lipi...lass of TLR2 Ligands Capable of Enhancing Autoimmu...American Journal of Pathology . , Multiple scler...ks the brain and spinal cord, affects nearly 1 in ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Holistic Success How To Achieve Health Happiness and Genuine Success 3A A Web TV Premiere 58744 1Holistic Success How To Achieve Health Happiness and Genuine Success 3A A Web TV Premiere 58744 2Biostar Pharmaceuticals Inc Receives Patent for Aoxing Ganbao 5185 1Biostar Pharmaceuticals Inc Receives Patent for Aoxing Ganbao 5185 2Biostar Pharmaceuticals Inc Receives Patent for Aoxing Ganbao 5185 3Professor Jens Reich first recipient of the Carl Friedrich von Weizsacker award 10232 1Professor Jens Reich first recipient of the Carl Friedrich von Weizsacker award 10232 2Professor Jens Reich first recipient of the Carl Friedrich von Weizsacker award 10232 3
...p an onion and you risk crying over your cutting b...nd nose. Scientists do not know why certain chemic...re so highly irritating, but new research in mice ...l cavity cells. Researchers funded by the National...orders (NIDCD), part of the National Institutes of...
... living in the oceans play a critical role in regu...n about their activities and how they work togethe...and energy. , A team of MIT researchers led by P...ng to change that. , Borrowing gene sequencing ...he researchers have devised a new method to analyz...
...percent of the worlds carbonmore than the atmosphe...rbon dynamics to predict whether anthropogenic glo... pools. Helene Muller-Landau, staff scientist at t...ced a major global research effort to quantify for... effort at the Climate Change in the Americas Symp...
Other Biology News:Irritating smells alert special cells, NIH-funded study finds 2Irritating smells alert special cells, NIH-funded study finds 3Team probes mysteries of oceanic bacteria 2Smithsonian announces Global Forest Carbon Research Initiative 2
...ed for Optimal Microdissection , CapSure HS and C... extraction of populations of pure cells from tiss...e Microdissection., Ensure the Integrity of Micr... , All CapSure LCM Caps have a patented transfer ...
...n system is used for single-color real-time detect...rophores and features a real-time PCR thermal grad... from 96 wells, a gene expression macro for relati...is. The system includes the optical module and opt...
...ed for Optimal Microdissection , CapSure HS and C... extraction of populations of pure cells from tiss...e Microdissection., Ensure the Integrity of Micr... , All CapSure LCM Caps have a patented transfer ...
DNA Engine Opticon Continuous Fluorescence Detection System from Bio-Rad
Biology Products: